Oppenheimer Begins Coverage on Harmony Biosciences (NASDAQ:HRMY)
Oppenheimer initiated coverage on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research note released on Monday, MarketBeat.com reports. The brokerage issued an outperform rating and a $61.00 price target on the stock. Several other analysts have also recently issued reports on HRMY. Cantor Fitzgerald raised shares of Harmony Biosciences to a “strong-buy” […]
Oppenheimer initiated coverage on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research note released on Monday, MarketBeat.com reports. The brokerage issued an outperform rating and a $61.00 price target on the stock. Several other analysts have also recently issued reports on HRMY. Cantor Fitzgerald raised shares of Harmony Biosciences to a “strong-buy” […]
